Search

everythinglearnresearchcommunity

for

Search:↓

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Hair transplant surgery is the most effective, safe, and satisfying treatment for hair loss.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

Minoxidil can increase hair density, speed up regrowth in transplanted hair, and slow down further hair loss, especially beneficial for women, young men with thinning hair, and those wanting to reconstruct the back of the scalp.

Oral minoxidil may slow male pattern baldness and cause body hair growth, but hair loss can happen after stopping it.

Short Anagen Syndrome causes persistently short hair and increased shedding, usually improving after puberty.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

Male hair loss is mainly due to thinner hair, not less hair.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Low-level light therapy, possibly combined with other treatments, may become a leading hair loss treatment, while hirsutism often worsens with age and lacks preventive options.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Sublingual minoxidil safely promotes hair growth.

Minoxidil helps stabilize hair loss, increase density, and reduce shedding after hair transplant surgery.

Using both topical and oral minoxidil doesn't significantly reduce temporary hair shedding.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Minoxidil can help grow hair and make hair follicles bigger, but it can also cause side effects.

Minoxidil works faster and is more cost-effective for treating hair loss, but platelet-rich plasma microneedling can be an alternative for those who can't use minoxidil.